Stryker Receives FDA Warning Letter Following Class I Recall
This article was originally published in The Gray Sheet
Executive Summary
The FDA letter cites Stryker for failing to notify FDA of a product recall and for illegally marketing devices, including the Neptune waste management system.
You may also be interested in...
Regulatory News In Brief
Johnson & Johnson/LifeScan is recalling nearly 2 million blood glucose meters in the U.S. and overseas. Court rules in favor of FDA in Cytori 510(k) substantial equivalence case. More regulatory news.
Regulatory News In Brief
Federal and state regulatory news updates.
Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot
In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?